After Failed Laminectomy: Finding Relief with Intra-Annular Fibrin Injection

At ValorSpine, we often encounter patients who have endured years of chronic back pain, sometimes even after undergoing traditional surgical interventions. These individuals represent some of the most challenging, yet most rewarding, cases we treat. They come to us having exhausted conventional options, often feeling hopeless, and frequently facing the daunting prospect of additional, more invasive surgeries. This case study details the journey of Sergeant David Miller, a 55-year-old Army Infantry Veteran who, after an initial laminectomy and subsequent development of adjacent segment disease, found significant relief and renewed quality of life through intra-annular fibrin injection.

Patient Overview

Sergeant David Miller, a dedicated Army Infantry Veteran, served our nation for over two decades, participating in numerous demanding deployments. His service involved extensive physical strain, including years of rucking with heavy loads (often 60-80 lbs) and enduring the jarring impacts of multiple jumps. These cumulative stresses, common among combat personnel, took a significant toll on his spine. Eight years prior to visiting ValorSpine, Sergeant Miller underwent an L5-S1 laminectomy and fusion to address a severely herniated disc and instability that had been causing debilitating sciatica and low back pain.

While the initial surgery provided temporary relief for his L5-S1 issues, over the subsequent years, Sergeant Miller began experiencing a familiar, yet distinct, pattern of pain. At 55 years old, he presented to ValorSpine with chronic, severe lower back pain, often radiating into his left buttock and thigh, with occasional numbness. His pain level consistently hovered at a 7-8 out of 10 on a daily basis, significantly impacting his ability to function. Diagnostic imaging revealed a new problem: adjacent segment disease (ASD) at the L4-L5 level, immediately above his previously fused L5-S1 segment. Specifically, his MRI showed clear evidence of degenerative disc disease at L4-L5, accompanied by annular tears visible on advanced imaging, indicating the source of his persistent discogenic pain.

The Challenge

Sergeant Miller’s situation was particularly complex and emotionally taxing. The recurrence of severe pain, especially after a major spinal surgery, had left him deeply frustrated and disheartened. His initial L5-S1 fusion was meant to be a definitive solution, and the development of adjacent segment disease felt like a cruel setback. He described his pain as a constant, grinding ache in his lower back, exacerbated by sitting, standing for prolonged periods, and any attempt at moderate physical activity. This pain was not only physically draining but also mentally exhausting. He was no longer able to engage in many of the activities he once cherished, such as golfing, hiking, or even simply playing actively with his grandchildren. Long car rides, once a pleasant way to visit family, became unbearable ordeals, often necessitating multiple stops for stretching and pain medication. His sleep was frequently interrupted, and his overall mood and outlook on life had significantly deteriorated. The shadow of “failed back surgery syndrome” loomed large, and the prospect of facing yet another complex spinal operation, with its inherent risks and prolonged recovery, filled him with dread.

The L4-L5 disc, now showing signs of advanced degeneration and annular tears, was struggling to compensate for the rigidity of the fused segment below it. This biomechanical stress is a well-known consequence of spinal fusion, leading to accelerated wear and tear on the adjacent discs. Sergeant Miller’s pain was clearly discogenic, meaning it originated from the damaged and inflamed disc itself, rather than solely from nerve compression, although he did experience intermittent radicular symptoms due to the disc’s condition. Traditional treatments had offered only fleeting relief, and he was desperate for an alternative that could address the root cause of his pain without resorting to more extensive surgery.

Previous Treatments Tried

Prior to his visit to ValorSpine, Sergeant Miller had pursued a wide array of conventional treatments, both before and after his initial L5-S1 laminectomy and fusion. Over the years, he had undergone numerous rounds of physical therapy, focusing on core strengthening, flexibility, and posture. While these provided some temporary symptomatic relief, they failed to address the underlying structural issue of his degenerating L4-L5 disc and annular tears.

He had received multiple epidural steroid injections, administered by various pain management specialists. These injections would offer a short-lived reduction in inflammation and pain, typically lasting a few weeks to a couple of months, but the pain would inevitably return with its previous intensity. The transient nature of the relief, coupled with the diminishing efficacy of repeated injections, left him feeling increasingly discouraged.

Sergeant Miller had also explored chiropractic care and various non-steroidal anti-inflammatory drugs (NSAIDs), as well as stronger prescription pain medications when his pain flared. While these offered symptomatic management, they did not contribute to any long-term healing or structural improvement. His pain management regimen had become a complex cycle of temporary fixes, with no real hope of lasting resolution.

Crucially, after being diagnosed with adjacent segment disease at L4-L5, he was advised by several orthopedic surgeons that the next logical step would be a revision fusion surgery, extending his previous fusion to include the L4-L5 segment. This recommendation, while surgically conventional for ASD, presented Sergeant Miller with a deeply unappealing future: another lengthy recovery, the potential for further adjacent segment disease above the new fusion, and the irreversible loss of more spinal mobility. He was actively seeking a less invasive option that could potentially heal his disc rather than simply fuse another segment.

Our Approach

At ValorSpine, our philosophy centers on identifying and treating the root cause of chronic spinal pain with minimally invasive, regenerative solutions. When Sergeant Miller presented his case, our team understood the profound need for a different approach, especially given his history of failed surgery and the looming threat of another fusion. Our diagnostic process began with a thorough review of his extensive medical history, including all previous imaging (X-rays, CT scans, and MRIs), and a comprehensive physical examination.

Recognizing the discogenic nature of his pain at L4-L5, we performed a highly specialized diagnostic procedure: a provocative discography. This test, conducted under fluoroscopic guidance, involves injecting a small amount of saline into the suspected disc (L4-L5 in Sergeant Miller’s case) to precisely identify if that particular disc is the source of his pain. Sergeant Miller’s discography unequivocally reproduced his familiar back and leg pain, confirming the L4-L5 disc and its annular tears as the primary pain generator.

With this confirmation, our team discussed the most appropriate course of action. Given the presence of clear annular tears and degenerative changes within the L4-L5 disc, Sergeant Miller was deemed an excellent candidate for intra-annular fibrin injection. This biologic disc repair treatment offered a compelling alternative to surgical fusion. Our approach was to leverage the healing properties of fibrin to seal the annular tears, stabilize the disc, and promote an environment for natural tissue repair. This represented a fundamental shift from simply managing symptoms or fusing segments; instead, we aimed to facilitate actual biological healing within the damaged disc itself.

We explained to Sergeant Miller that this procedure is designed to strengthen the annulus fibrosis – the tough outer ring of the disc – where the tears were allowing the inner nucleus material to protrude or leak, causing pain and inflammation. By injecting fibrin directly into these tears, we aimed to provide a scaffold for healing, encourage the growth of new, healthy tissue, and restore the disc’s structural integrity. This regenerative strategy offered him the hope of pain relief, improved function, and, most importantly, the chance to avoid another major spinal surgery.

Treatment Process

Sergeant Miller’s intra-annular fibrin injection procedure was meticulously planned and executed as an outpatient procedure at ValorSpine. On the day of the treatment, he arrived relaxed and informed, having had all his questions thoroughly answered by our medical team. The procedure itself is minimally invasive, performed with the highest standards of safety and precision.

Under strict sterile conditions and guided by real-time fluoroscopy (X-ray imaging), a highly skilled ValorSpine physician carefully advanced a fine needle directly into the L4-L5 disc, specifically targeting the identified annular tears. Throughout the procedure, Sergeant Miller was awake but comfortable, receiving mild sedation and local anesthetic to ensure his comfort. This allowed for continuous communication with the medical team, ensuring precise needle placement and monitoring his responses.

Once the needle was optimally positioned within the disc and its tears, a specialized fibrin sealant, a natural protein involved in blood clotting and tissue repair, was carefully injected. This biologic agent works by filling and sealing the annular tears, providing an immediate structural scaffold. More importantly, it initiates a long-term healing cascade, attracting fibroblasts and other regenerative cells to the site to promote the growth of new, healthy collagen fibers, thereby strengthening the compromised annulus.

The procedure itself took approximately 60-90 minutes. Following the injection, Sergeant Miller spent a short period in our recovery area for observation, where his vital signs were monitored, and he was given post-procedure instructions. He was able to walk out of the clinic the same day, accompanied by a family member, and advised to engage in a period of restricted activity for the initial few weeks to allow the healing process to begin undisturbed. This post-procedure protocol emphasized avoiding heavy lifting, twisting, and prolonged sitting, and gradually reintroducing light activities as tolerated, under the guidance of our physical therapy team. Regular follow-up appointments were scheduled to monitor his progress and adjust his rehabilitation plan as needed.

The Results

Sergeant Miller’s journey to recovery, while steady, was not instantaneous, aligning with the expected timeline for biologic healing. In the immediate days following the intra-annular fibrin injection, he experienced a temporary increase in localized discomfort at the injection site, which is a normal part of the initial healing response. This was managed effectively with over-the-counter pain relievers and ice. Adhering strictly to his post-procedure activity restrictions, he began to notice subtle shifts in his pain levels by week three.

By the two-month mark, Sergeant Miller reported a noticeable improvement. His daily pain, which had been a persistent 7-8/10, had reduced to a more manageable 4-5/10. He found he could sit for longer periods without the intense burning sensation, and the radiating pain into his left buttock and thigh became less frequent and less severe. He was able to begin light walking for exercise, something that had previously exacerbated his symptoms. This moderate improvement provided him with significant encouragement and renewed hope after years of despair.

At four months post-procedure, Sergeant Miller’s progress was even more substantial. He proudly reported his pain consistently hovering at a 2-3/10, representing a significant improvement of over 60% from his pre-treatment baseline. The nagging low back ache had largely subsided, and the occasional radicular symptoms were mild and easily managed. He was thrilled to be able to enjoy longer car rides to visit his children without constant discomfort. He had gradually resumed some of his recreational activities, including regular walks in the park and even practicing his golf swing at home, though not yet returning to the course fully.

Six months after his intra-annular fibrin injection, Sergeant Miller’s transformation was remarkable. His pain had stabilized at a low 1-2/10 for most days, representing a greater than 70% reduction in his pain scores. The improvement in his quality of life was profound. He was actively playing with his grandchildren, able to bend and lift without fear, and had even returned to the golf course for 9 holes, albeit with a modified swing. His sleep quality improved dramatically, and he was able to significantly reduce his reliance on pain medications. Most importantly, he had completely avoided the previously recommended revision fusion surgery, preserving his spinal mobility and preventing further complex interventions.

Follow-up imaging at 12 months showed encouraging signs of disc healing and stabilization at the L4-L5 level, corresponding with his sustained clinical improvement. While not a “cure-all” and results vary among individuals, Sergeant Miller’s case stands as a powerful testament to the potential of biologic disc repair in addressing complex discogenic pain, even in the context of adjacent segment disease after previous spinal surgery.

Key Takeaways

Sergeant David Miller’s case vividly illustrates the profound impact of chronic discogenic pain, especially when it arises as adjacent segment disease following prior spinal fusion. His journey underscores several critical takeaways for both patients and healthcare providers:

1. **The Persistent Challenge of Adjacent Segment Disease:** Spinal fusion, while effective for certain conditions, can create biomechanical stresses on the discs immediately above and below the fused segment. These “adjacent segments” can degenerate at an accelerated rate, leading to new pain and functional limitations, as seen in Sergeant Miller’s L4-L5 disc.
2. **Limits of Conventional Treatments for Discogenic Pain:** While physical therapy, injections, and pain medications offer symptomatic relief, they often fail to address the underlying structural damage (annular tears, disc degeneration) that causes discogenic pain. For patients like Sergeant Miller, who have exhausted these options, a different strategy is crucial.
3. **The Promise of Biologic Disc Repair:** Intra-annular fibrin injection offers a compelling, minimally invasive alternative to repeat spinal surgery for specific types of disc damage, particularly annular tears and early to moderate degenerative disc disease. By sealing tears and promoting the body’s natural healing processes, it aims to restore disc integrity and alleviate pain at its source.
4. **Avoiding Further Invasive Surgery:** For patients facing the daunting prospect of revision fusion, treatments like fibrin disc treatment provide a less invasive pathway to significant pain relief and improved function, preserving spinal mobility and avoiding the risks associated with complex surgery.
5. **Hope for “Failed Back Surgery” Patients:** Sergeant Miller’s success demonstrates that even individuals with a history of spinal surgery and subsequent chronic pain can find meaningful relief and reclaim their quality of life. It highlights the importance of seeking specialized care that offers advanced diagnostic and regenerative treatment options.

ValorSpine is dedicated to providing hope and effective solutions for individuals suffering from chronic spinal pain, even in the most challenging scenarios. Sergeant Miller’s story is a powerful reminder that with the right diagnostic approach and innovative biologic treatments, lasting relief is achievable.

“After my first surgery, I thought I was doomed to a lifetime of pain, especially when they told me I needed another fusion. ValorSpine gave me my life back. The fibrin treatment wasn’t just another temporary fix; it truly healed something inside. I can finally enjoy my retirement, my grandkids, and even get back on the golf course. It’s a miracle for me.”

— Sergeant David Miller, Army Infantry Veteran

If you would like to read more, we recommend this article: After Failed Laminectomy: Finding Relief with Intra-Annular Fibrin Injection